Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

531 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Experience with sorafenib and adverse event management.
Bellmunt J, Eisen T, Fishman M, Quinn D. Bellmunt J, et al. Crit Rev Oncol Hematol. 2011 Apr;78(1):24-32. doi: 10.1016/j.critrevonc.2010.03.006. Epub 2010 Apr 18. Crit Rev Oncol Hematol. 2011. PMID: 20399677 Review.
New drugs and new approaches in metastatic bladder cancer.
Bellmunt J, de Wit R, Albiol S, Tabernero J, Albanell J, Baselga J. Bellmunt J, et al. Crit Rev Oncol Hematol. 2003 Aug;47(2):195-206. doi: 10.1016/s1040-8428(03)00082-9. Crit Rev Oncol Hematol. 2003. PMID: 12900012 Review.
Sorafenib TARGET trial results in Spanish patients.
Bellmunt J, González-Larriba JL, Climent MA, López-Vivanco G, Urruticoechea L, Albanell J. Bellmunt J, et al. Clin Transl Oncol. 2007 Oct;9(10):671-3. doi: 10.1007/s12094-007-0120-6. Clin Transl Oncol. 2007. PMID: 17974528 Clinical Trial.
Prostate cancer. Multidisciplinary approach: a key to success.
Montagut C, Albanell J, Bellmunt J. Montagut C, et al. Among authors: bellmunt j. Crit Rev Oncol Hematol. 2008 Oct;68 Suppl 1:S32-6. doi: 10.1016/j.critrevonc.2008.07.009. Epub 2008 Aug 23. Crit Rev Oncol Hematol. 2008. PMID: 18723370 Review.
531 results